Approval of Unaudited Financial Results for Quarter and Half year ended on September 30, 2025.
Awaiting price reaction for this filing.
Omkar Specialty Chemicals Ltd has submitted unaudited financial results for Q2 and H1 FY26 (ending September 2025). The company's auditor R.R. Tibrewala & Co. issued a qualified conclusion due to three key concerns: (1) The company was under Corporate Insolvency Resolution Process (CIRP) during the period, (2) prior quarter results for FY2024-25 were not prepared, making comparisons unavailable, and (3) the company reported losses with negative net worth. Despite the going concern uncertainty, financials were prepared on a going concern basis following NCLT approval of a Resolution Plan on 31 July 2025. The auditor also drew an emphasis of matter on the NCLT-approved resolution plan.
The qualified opinion and negative net worth signal significant financial stress, though NCLT approval of the resolution plan offers a potential path to recovery. Shareholders should monitor whether the resolution plan execution stabilizes operations and restores profitability.